Patents by Inventor Nathaniel J. Washburn

Nathaniel J. Washburn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Sialylated Glycoproteins
    Publication number: 20240167069
    Abstract: Glycoproteins having particular sialylation patterns, and methods of making and using such glycoproteins, are described.
    Type: Application
    Filed: July 6, 2023
    Publication date: May 23, 2024
    Inventors: Naveen Bhatnagar, Robin Meccariello, Jonathan C. Lansing, Daniel Ortiz, Hetal Sarvaiya, Nathaniel J. Washburn
  • Sialylated Glycoproteins
    Publication number: 20240141401
    Abstract: Glycoproteins having particular sialylation patterns, and methods of making and using such glycoproteins, are described.
    Type: Application
    Filed: June 30, 2023
    Publication date: May 2, 2024
    Inventors: Naveen Bhatnagar, Robin Meccariello, Jonathan C. Lansing, Daniel Ortiz, Hetal Sarvaiya, Nathaniel J. Washburn
  • SIALYLATED GLYCOPROTEINS
    Publication number: 20230417762
    Abstract: Methods for measuring disialylated Fc glycan in a biological sample are described.
    Type: Application
    Filed: November 19, 2021
    Publication date: December 28, 2023
    Inventors: Nathaniel J. WASHBURN, Daniel ORTIZ, John SCHAECK
  • GLYCOPROTEINS WITH ANTI-INFLAMMATORY PROPERTIES
    Publication number: 20220056109
    Abstract: Glycoproteins having particular sialylation patterns, and methods of making and using such glycoproteins, are described.
    Type: Application
    Filed: October 22, 2021
    Publication date: February 24, 2022
    Inventors: Hetal Sarvaiya, Nathaniel J. Washburn, Enrique Arevalo, Carlos J. Bosques
  • COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS
    Publication number: 20220049019
    Abstract: The present disclosure relates to engineered IgG Fc constructs and uses thereof.
    Type: Application
    Filed: October 1, 2021
    Publication date: February 17, 2022
    Inventors: Carlos J. Bosques, Jonathan C. Lansing, Daniel Ortiz, Laura Rutitzky, Nathaniel J. Washburn
  • FCRN ANTIBODY COMPOSITIONS
    Publication number: 20210340251
    Abstract: This disclosure pertains to compositions comprising an anti-FcRn antibody, M281. The compositions include the full, intact antibody and size variants thereof that not include two antibody heavy chains and to antibody light chains. Thus, a M281 pharmaceutical composition can include: an antibody comprising a heavy chain comprising the amino acid sequence of SEQ ID NO:2 and a light chain comprising the amino acid sequence of SEQ ID NO:1, wherein the composition comprises a major protein component having a molecular weight of 140,00-145,000 Da and a minor protein component of molecular weight 118,000-120,000 Da.
    Type: Application
    Filed: July 19, 2019
    Publication date: November 4, 2021
    Inventors: Zhongli ZHANG, Michael SHIFRIN, Nathaniel J. WASHBURN, Aneta LIWOSZ, Nasir KHAN
  • Compositions and methods related to engineered Fc constructs
    Patent number: 11155640
    Abstract: The present invention relates to engineered IgG Fc constructs and uses thereof.
    Type: Grant
    Filed: May 23, 2017
    Date of Patent: October 26, 2021
    Assignee: Janssen Biotech, Inc.
    Inventors: Carlos J. Bosques, Jonathan C. Lansing, Daniel Ortiz, Laura Rutitzky, Nathaniel J. Washburn
  • Sialylated Glycoproteins
    Publication number: 20210277438
    Abstract: Glycoproteins having particular sialylation patterns, and methods of making and using such glycoproteins, are described.
    Type: Application
    Filed: November 20, 2020
    Publication date: September 9, 2021
    Inventors: Naveen Bhatnagar, Robin Meccariello, Jonathan C. Lansing, Daniel Ortiz, Hetal Sarvaiya, Nathaniel J. Washburn
  • Sialylated Glycoproteins
    Publication number: 20210040527
    Abstract: Glycoproteins having particular sialylation patterns, and methods of making and using such glycoproteins, are described.
    Type: Application
    Filed: September 25, 2020
    Publication date: February 11, 2021
    Inventors: Naveen Bhatnagar, Robin Meccariello, Jonathan C. Lansing, Daniel Ortiz, Hetal Sarvaiya, Nathaniel J. Washburn
  • Sialylated Glycoproteins
    Publication number: 20210017563
    Abstract: Glycoproteins having particular sialylation patterns, and methods of making and using such glycoproteins, are described.
    Type: Application
    Filed: September 25, 2020
    Publication date: January 21, 2021
    Inventors: Naveen Bhatnagar, Robin Meccariello, Jonathan C. Lansing, Daniel Ortiz, Hetal Sarvaiya, Nathaniel J. Washburn
  • SIALYLATED GLYCOPROTEINS
    Publication number: 20200032312
    Abstract: Glycoproteins having particular sialylation patterns, and methods of making and using such glycoproteins, are described.
    Type: Application
    Filed: October 1, 2019
    Publication date: January 30, 2020
    Inventors: Naveen Bhatnagar, Robin Meccariello, Jonathan C. Lansing, Daniel Ortiz, Hetal Sarvaiya, Nathaniel J. Washburn
  • COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS
    Publication number: 20190284305
    Abstract: The present invention relates to engineered IgG Fc constructs and uses thereof.
    Type: Application
    Filed: May 23, 2017
    Publication date: September 19, 2019
    Inventors: Carlos J. Bosques, Jonathan C. Lansing, Daniel Ortiz, Laura Rutitzky, Nathaniel J. Washburn
  • Modified glycoproteins
    Patent number: 10377809
    Abstract: Sulfated glycoproteins, and methods of making and using such sulfated glycoproteins, are described.
    Type: Grant
    Filed: April 10, 2017
    Date of Patent: August 13, 2019
    Assignee: Momenta Pharmaceuticals, Inc.
    Inventors: Dorota A. Bulik, Carlos J. Bosques, Brian Edward Collins, Maurice Gaston Hains, Nathaniel J. Washburn, James Meador, Sean Smith, Naveen Bhatnagar
  • GLYCOPROTEINS WITH ANTI-INFLAMMATORY PROPERTIES
    Publication number: 20180305440
    Abstract: Glycoproteins having particular sialylation patterns, and methods of making and using such glycoproteins, are described.
    Type: Application
    Filed: April 19, 2018
    Publication date: October 25, 2018
    Inventors: Hetal Sarvaiya, Nathaniel J. Washburn, Enrique Arevalo, Carlos J. Bosques
  • MODIFIED GLYCOPROTEINS
    Publication number: 20170247426
    Abstract: Sulfated glycoproteins, and methods of making and using such sulfated glycoproteins, are described.
    Type: Application
    Filed: April 10, 2017
    Publication date: August 31, 2017
    Inventors: Dorota A. Bulik, Carlos J. Bosques, Brian Edward Collins, Maurice Gaston Hains, Nathaniel J. Washburn, James Meador, Sean Smith, Naveen Bhatnagar
  • Modified glycoproteins
    Patent number: 9650433
    Abstract: Sulfated glycoproteins, and methods of making and using such sulfated glycoproteins, are described.
    Type: Grant
    Filed: May 18, 2012
    Date of Patent: May 16, 2017
    Assignee: Momenta Pharmaceuticals, Inc.
    Inventors: Dorota A. Bulik, Carlos J. Bosques, Brian Edward Collins, Maurice Gaston Hains, Nathaniel J. Washburn, James Meador, Sean Smith, Naveen Bhatnagar
  • N-acetylhexosamine-containing N-glycans in glycoprotein products
    Patent number: 9170249
    Abstract: The present invention provides methods of evaluating a glycoprotein preparation for the absence, presence or amount of an N-acetylhexosamine glycan, e.g., an N-acetylglucosamine glycan.
    Type: Grant
    Filed: March 12, 2012
    Date of Patent: October 27, 2015
    Assignee: MOMENTA PHARMACEUTICALS, INC.
    Inventors: Nathaniel J. Washburn, Enrique Arevalo, Kevin Millea, Carlos J. Bosques, Jay Duffner, Brian E. Collins
  • GLYCOPROTEIN PREPARATIONS
    Publication number: 20150252108
    Abstract: Preparations of glycoproteins, e.g., therapeutic preparations of glycoproteins, having altered levels of affinity for Fc? receptors relative to reference glycoprotein preparations, and methods of making and methods of using such preparations, are described.
    Type: Application
    Filed: September 25, 2013
    Publication date: September 10, 2015
    Applicant: Momenta Pharmaceuticals, Inc.
    Inventors: Nathaniel J. Washburn, Jonathan C. Lansing, Carlos J. Bosques, Naveen Bhatnagar, Dorota A. Bulik, Lynn Markowitz, Sandra Sipsey
  • MODIFIED GLYCOPROTEINS
    Publication number: 20140112910
    Abstract: Sulfated glycoproteins, and methods of making and using such sulfated glycoproteins, are described.
    Type: Application
    Filed: May 18, 2012
    Publication date: April 24, 2014
    Applicant: MOMENTA PHARMACEUTICALS, INC.
    Inventors: Dorota A. Bulik, Carlos J. Bosques, Brian Edward Collins, Maurice Gaston Hains, Nathaniel J. Washburn, James Meador, Sean Smith, Naveen Bhatnagar
  • N-ACETYLHEXOSAMINE-CONTAINING N-GLYCANS IN GLYCOPROTEIN PRODUCTS
    Publication number: 20120295273
    Abstract: The present invention provides methods of evaluating a glycoprotein preparation for the absence, presence or amount of an N-acetylhexosamine glycan, e.g., an N-acetylglucosamine glycan.
    Type: Application
    Filed: March 12, 2012
    Publication date: November 22, 2012
    Inventors: Nathaniel J. Washburn, Enrique Arevalo, Kevin Millea, Carlos J. Bosques, Jay Duffner, Brian E. Collins